Identification and analysis associated with the onset and progression of adult T-cell leukemia

与成人 T 细胞白血病发病和进展相关的鉴定和分析

基本信息

  • 批准号:
    09671125
  • 负责人:
  • 金额:
    $ 1.98万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1998
  • 项目状态:
    已结题

项目摘要

Adult T-cell leukemia (ATL) is an aggressive neoplasm of helper T-lymphocytes, which is etiologically associated with human T-cell leukemia virus type I (HTLV-I). Siince its long latent period from infection of HTLV-I to onset of ATL, multti-step mechanism of leukemogenesis is considered in ATL.We are trying to identify the genes responsible for the onset and the progression of ATL.Although leukemic cells in most ATL cases expressed Fas antigen, we found Fas-negative cases. Neutrophil from this patient had Fas antigen on the surface, showing that Fas-negative phenotype is specific to leukemie cells. Sequences of RT-PCR products revealed that skipping of exon 4, and small deletion (5bp) caused premature termination of Fas protein synthesis, resulting in Fas negative phenotype. This Fas negative ATL cells were resistant to doxorubicin -induced apoptosis in vitro. Fas negative phenotype is considered to be associated with drug resistance.Methylation of the p16^<INK4A> gene has been recogn … More ized as another mechanism, in addition to somatic DNA changes such as deletion or mutation, which can inactivate the pl6^<INK4A> gene in various malignancies including melanoma, bladder cancer and malignant lymphoma. We analyzed the methylation of the p16^<INK4A> gene in patients with different subtypes of adult T-cell leukemia (ATL). Using Southern blot analysis and methylation-specific PCR (MSPCR), we detected methylation of the p16^<INK4A> gene was more frequently in acute ATL (49%) or lymphoma-type ATL (73%) than in lowgrade malignant stage, chronic (17%) and smoldering types (17%). In contrast, no methylation of the pl6^<INK4A> gene was found in asymptomatic HTLV-I carriers and uninfected control, and methylation of the p15 gene, which encode another inhibitor of CDK4 and 6, could not be found in any ATL samples : methylation of the p16^<INK4A> gene is highly specific for ATL.Deletion of the the p16^<INK4A> gene was found in another 20% of acute ATL patients by Southern blot analysis, and therefore, abnormalities of the p16^<INK4A> gene in acute ATL total to 69%. Furthermore, direct sequencing of the pl6^<INK4A> gene after sodium bisulfite treatment of genomic DNA revealed that the methylation of CpG sites occurred in most (23 out of 29) of ATL cases including chronic or smoldering ATL, even in the cases which methylation could not be detected by MSPCR or the Southern blot method. Semi-quantitative PCR showed markedly decreased p16^<INK4A> mRNA levels in the samples having a methylated p16^<INK4A> gene. These findings show that a level of CpG methylation plays an important role in the progression of ATL by further decreasing the expression of p16. Less
成人t细胞白血病(ATL)是一种辅助性t淋巴细胞的侵袭性肿瘤,其病因学与人t细胞白血病病毒I型(HTLV-I)相关。由于从HTLV-I感染到ATL发病潜伏期较长,ATL的白血病发生机制被认为是多步骤的。我们正试图找出导致ATL发病和发展的基因。虽然大多数ATL病例的白血病细胞表达Fas抗原,但我们发现Fas阴性病例。该患者的中性粒细胞表面有Fas抗原,表明Fas阴性表型是白血病细胞特有的。RT-PCR产物序列显示,外显子4的跳变和小缺失(5bp)导致Fas蛋白合成过早终止,导致Fas阴性表型。Fas阴性ATL细胞对阿霉素诱导的体外凋亡具有抗性。Fas阴性表型被认为与耐药有关。p16^<INK4A>基因的甲基化已被认为是除体细胞DNA改变(如缺失或突变)外的另一种机制,它可以使pl6^<INK4A>基因失活,包括黑色素瘤、膀胱癌和恶性淋巴瘤。我们分析了不同亚型成人t细胞白血病(ATL)患者p16^<INK4A>基因的甲基化。通过Southern blot分析和甲基化特异性PCR (MSPCR),我们检测到p16^<INK4A>基因的甲基化在急性ATL(49%)或淋巴瘤型ATL(73%)中比在低恶性期、慢性(17%)和阴烧型(17%)中更频繁。相比之下,在无症状HTLV-I携带者和未感染对照中未发现pl6^<INK4A>基因的甲基化,编码另一种CDK4和6抑制剂的p15基因的甲基化在任何ATL样本中均未发现:p16^<INK4A>基因的甲基化对ATL具有高度特异性。Southern blot分析发现,另外20%的急性ATL患者存在p16^<INK4A>基因缺失,因此急性ATL患者p16^<INK4A>基因异常占69%。此外,亚硫酸氢钠处理基因组DNA后,对pl6^<INK4A>基因的直接测序显示,包括慢性或阴燃ATL在内的大多数ATL病例(29例中的23例)发生了CpG位点的甲基化,即使在MSPCR或Southern blot方法无法检测到甲基化的情况下也是如此。半定量PCR显示p16^<INK4A>基因甲基化的样品中p16^<INK4A> mRNA水平显著降低。这些发现表明,CpG甲基化水平通过进一步降低p16的表达在ATL的进展中起重要作用。少

项目成果

期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Etoh K,Matsuoka M,et al.: "Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo" Cancer Research. 57. 4862-4867 (1997)
Etoh K、Matsuoka M 等人:“人 T 淋巴细胞病毒 I 型感染细胞在体内的持续克隆增殖”癌症研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Inoue M,Matsuoka M,et al: "Characterization of mRNA expression of IkappaB alpha and NF-kappaB subfamilies in primary adult T-cell leukemia cells." Jpn.J.of Cancer Res.89. 53-59 (1998)
Inoue M、Matsuoka M 等人:“原代成人 T 细胞白血病细胞中 IkappaB α 和 NF-kappaB 亚家族 mRNA 表达的表征。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
松岡 雅雄、他: "成人T細胞白血病リンパ腫. 悪性リンパ腫治療マニュアル" 南江堂, 213 (1998)
Masao Matsuoka等人:“成人T细胞白血病淋巴瘤。恶性淋巴瘤治疗手册” Nankodo,213(1998)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Etoh K-I,Matsuoka M,et al: "Rapid quantification of HTLV-I provirus load : detection of monoclonal proliferation of HTLV-I-infected cells among blood donors." Int.J.Cancer. (in press).
Etoh K-I、Matsuoka M 等人:“HTLV-I 原病毒载量的快速定量:检测献血者中 HTLV-I 感染细胞的单克隆增殖。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tekemoto, S., et al.: "Proliferation of asult T cell leukemia/lymphoma cells is assiciated with the constitutive activation of JAK/STAT proteins." Proc. Natl. Acad. Sci. USA. 94. 13897-13902 (1997)
Tekemoto, S. 等人:“T 细胞白血病/淋巴瘤细胞的增殖与 JAK/STAT 蛋白的组成型激活有关。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MATSUOKA Masao其他文献

MATSUOKA Masao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MATSUOKA Masao', 18)}}的其他基金

Inflammation and immunological dysfunction by HTLV-1 bZIP factor in HTLV-1 associated dieases
HTLV-1 bZIP 因子在 HTLV-1 相关疾病中的炎症和免疫功能障碍
  • 批准号:
    22390193
  • 财政年份:
    2010
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The role of HTLV-1 encoded HBZ gene in the pathogenesis
HTLV-1编码的HBZ基因在发病机制中的作用
  • 批准号:
    19390263
  • 财政年份:
    2007
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanism of leukemogenesis in ATL
ATL白血病发生的分子机制
  • 批准号:
    17013046
  • 财政年份:
    2005
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Identification of aberrantly methylated DNA genes in hematological malignancies : its application to cancer diagnosis
血液恶性肿瘤中异常甲基化DNA基因的鉴定:其在癌症诊断中的应用
  • 批准号:
    14370301
  • 财政年份:
    2002
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanism of multi-step leukemogenesis in adult T-cell leukemia
成人T细胞白血病多步白血病发生的分子机制
  • 批准号:
    11671006
  • 财政年份:
    1999
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Designing and Surface Modification of Hydrogen Strage Alloy Material
储氢合金材料的设计及表面改性
  • 批准号:
    09650913
  • 财政年份:
    1997
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Study on the protective factors for total mortality among HTLV-I carriers
HTLV-I携带者总死亡率的保护因素研究
  • 批准号:
    20K10506
  • 财政年份:
    2020
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of a non-human primate model using cynomolgus monkeys for evaluating anti-HTLV-I mother to child infection drugs.
食蟹猴非人灵长类动物模型的建立,用于评价抗HTLV-I母婴感染药物。
  • 批准号:
    16K15285
  • 财政年份:
    2016
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
How HTLV-I Tax and HBZ control telomerase activity to induce adult T-cell leukemia
HTLV-I Tax 和 HBZ 如何控制端粒酶活性以诱导成人 T 细胞白血病
  • 批准号:
    9513500
  • 财政年份:
    2016
  • 资助金额:
    $ 1.98万
  • 项目类别:
How HTLV-I Tax and HBZ control telomerase activity to induce adult T-cell leukemia
HTLV-I Tax 和 HBZ 如何控制端粒酶活性以诱导成人 T 细胞白血病
  • 批准号:
    9304181
  • 财政年份:
    2016
  • 资助金额:
    $ 1.98万
  • 项目类别:
Role of HTLV-I Tax-induced NF-kB in activation of ICN1 and immortalization of vir
HTLV-I Tax诱导的NF-kB在ICN1激活和vir永生化中的作用
  • 批准号:
    8435077
  • 财政年份:
    2013
  • 资助金额:
    $ 1.98万
  • 项目类别:
Role of HTLV-I Tax-induced NF-kB in activation of ICN1 and immortalization of vir
HTLV-I Tax诱导的NF-kB在ICN1激活和vir永生化中的作用
  • 批准号:
    8606171
  • 财政年份:
    2013
  • 资助金额:
    $ 1.98万
  • 项目类别:
Elucidation of mechanism for HTLV-I-associated Sjogren's syndrome
阐明 HTLV-I 相关干燥综合征的机制
  • 批准号:
    25461477
  • 财政年份:
    2013
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The elucidation of the signalings of cytoskeletal reorganization involved in the development of HTLV-I-associated myelopathy
阐明参与 HTLV-I 相关脊髓病发生的细胞骨架重组信号
  • 批准号:
    24591267
  • 财政年份:
    2012
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of HTLV-I-specific anti-cancer therapy by using single chain T cell receptors and single chain trimers of MHC-I.
利用单链T细胞受体和MHC-I单链三聚体开发HTLV-I特异性抗癌疗法。
  • 批准号:
    24590547
  • 财政年份:
    2012
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mathematical epidemic models for the rapidly growing infection of HTLV-I
HTLV-I 感染迅速增长的数学流行病模型
  • 批准号:
    24540137
  • 财政年份:
    2012
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了